Received Jun 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | 57H54 | — |
accidentally administer a Menveo to a patient on June 17th 2025 instead of the Bexsero vaccine; interchange of vaccine products; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 21-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number 57H54, expiry date 31-JAN-2026) for prophylaxis. Co-suspect products included Men B NVS (Bexsero) for prophylaxis. Concomitant products included Meningococcal vaccine A/C/Y/W conj (dip tox) (Menactra) and Meningococcal vaccine A/C/Y/W conj (dip tox) (Menactra). On 17-JUN-2025, the patient received Menveo. On an unknown date, the patient did not receive Bexsero. On 17-JUN-2025, an unknown time after receiving Menveo and not applicable after receiving Bexsero, the patient experienced wrong vaccine administered (Verbatim: accidentally administer a Menveo to a patient on June 17th 2025 instead of the Bexsero vaccine) and interchange of vaccine products (Verbatim: interchange of vaccine products). The outcome of the wrong vaccine administered and interchange of vaccine products were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 20-JUN-2025 The medical assistant explained that they accidentally administered a Menveo to a patient instead of the Bexsero vaccine that was originally prescribed, which led to wrong vaccine administered. The patient received 2 prior doses of Menactra back and the reporter asked to the treating physician about it and they mentioned that nothing can happen from this mistake and the Menveo dose can be considered as a booster, which led to interchange of vaccine products
MENACTRA; MENACTRA